Translational Genomics (TG) is dedicated to publishing scientific advances in genomics and other omics technologies and its application in medicine. Areas covered by the journal include, but are not limited to precision medicine, genome informatics, systems medicine, genomics for diagnosis of genetic diseases, cancer genomics, population genetics, clinical epigenomics, modeling diseases, pathogen genomics and microbiome studies with clinical relevance and novel genomic technologies, assays, software or methodologies.
Peer Review Process
Authors should provide name, address and current email address of five potential expert reviewers. All articles submitted to the TG are subjected to two-tier review using our online peer review system. The preliminary review is conducted by an editor to make sure article conforms to the requirements of journal and research area is appropriate for the TG . The editor also ensures that article brings new scientific knowledge to the field. In the second stage of the review process, articles are assigned to expert reviewers from the field. Following feedback of reviewers, the editor makes the final decision on acceptance of the article.
Manuscript submitted by author --> Editor Preliminary review --> Expert Peer Reviewer --> Decision to Accept/Reject by Editor --> Submission of revised manuscript by author --> Article formatting and layout --> DOI assignment --> Publication on company of scientists website --> Archival of published articles
Open Access Policy
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
Translational Genomics (TG) journal is an open access journal of the The Company of Scientists and Physicians. All the above content is copyright protected by the The Company of Scientists and Physicians.